Source: ALL
Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 348
Gene Symbol: APOE
APOE 		0.200 GeneticVariation disease GWASCAT GBA and APOE ε4 associate with sporadic dementia with Lewy bodies in European genome wide association study. 31065058 2019
Entrez Id: 348
Gene Symbol: APOE
APOE 		0.200 GeneticVariation disease GWASCAT Genome-wide association meta-analysis of neuropathologic features of Alzheimer's disease and related dementias. 25188341 2014
Entrez Id: 348
Gene Symbol: APOE
APOE 		0.200 GeneticVariation disease GWASCAT Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study. 29263008 2018
Entrez Id: 55870
Gene Symbol: ASH1L
ASH1L 		0.110 GeneticVariation disease GWASCAT GBA and APOE ε4 associate with sporadic dementia with Lewy bodies in European genome wide association study. 31065058 2019
Entrez Id: 9274
Gene Symbol: BCL7C
BCL7C 		0.100 GeneticVariation disease GWASCAT Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study. 29263008 2018
Entrez Id: 101928736
Gene Symbol: MIR762HG
MIR762HG 		0.100 GeneticVariation disease GWASCAT Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study. 29263008 2018
Entrez Id: 100616231
Gene Symbol: MIR4519
MIR4519 		0.100 GeneticVariation disease GWASCAT Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study. 29263008 2018
Entrez Id: 6622
Gene Symbol: SNCA
SNCA 		0.800 Biomarker disease CTD_human Preliminary analyses have identified 2 proteins with lipoxidative damage, alpha-synuclein and manganese superoxide dismutase (SOD2), in incidentally Lewy body disease cortex. 16141792 2005
Entrez Id: 6622
Gene Symbol: SNCA
SNCA 		0.800 Biomarker disease CTD_human Metabolic activity determines efficacy of macroautophagic clearance of pathological oligomeric alpha-synuclein. 19628769 2009
Entrez Id: 6620
Gene Symbol: SNCB
SNCB 		0.700 Biomarker disease CTD_human
Entrez Id: 2629
Gene Symbol: GBA
GBA 		0.500 Biomarker disease CTD_human Lewy body disease (LBD) development is enhanced by mutations in the GBA gene coding for glucocerebrosidase (GCase). 22803570 2012
Entrez Id: 7054
Gene Symbol: TH
TH 		0.330 Biomarker disease CTD_human The PPARGC1A locus and CNS-specific PGC-1α isoforms are associated with Parkinson's Disease. 30236862 2019
Entrez Id: 2670
Gene Symbol: GFAP
GFAP 		0.320 Biomarker disease CTD_human Brain insulin-like growth factor and neurotrophin resistance in Parkinson's disease and dementia with Lewy bodies: potential role of manganese neurotoxicity. 19276553 2009
Entrez Id: 4803
Gene Symbol: NGF
NGF 		0.320 Biomarker disease CTD_human Brain insulin-like growth factor and neurotrophin resistance in Parkinson's disease and dementia with Lewy bodies: potential role of manganese neurotoxicity. 19276553 2009
Entrez Id: 1906
Gene Symbol: EDN1
EDN1 		0.310 Biomarker disease CTD_human Brain insulin-like growth factor and neurotrophin resistance in Parkinson's disease and dementia with Lewy bodies: potential role of manganese neurotoxicity. 19276553 2009
Entrez Id: 3481
Gene Symbol: IGF2
IGF2 		0.310 Biomarker disease CTD_human Brain insulin-like growth factor and neurotrophin resistance in Parkinson's disease and dementia with Lewy bodies: potential role of manganese neurotoxicity. 19276553 2009
Entrez Id: 6648
Gene Symbol: SOD2
SOD2 		0.310 Biomarker disease CTD_human Preliminary analyses have identified 2 proteins with lipoxidative damage, alpha-synuclein and manganese superoxide dismutase (SOD2), in incidentally Lewy body disease cortex. 16141792 2005
Entrez Id: 2026
Gene Symbol: ENO2
ENO2 		0.310 Biomarker disease CTD_human The PPARGC1A locus and CNS-specific PGC-1α isoforms are associated with Parkinson's Disease. 30236862 2019
Entrez Id: 4133
Gene Symbol: MAP2
MAP2 		0.300 Biomarker disease CTD_human The PPARGC1A locus and CNS-specific PGC-1α isoforms are associated with Parkinson's Disease. 30236862 2019
Entrez Id: 8678
Gene Symbol: BECN1
BECN1 		0.300 Biomarker disease CTD_human Metabolic activity determines efficacy of macroautophagic clearance of pathological oligomeric alpha-synuclein. 19628769 2009
Entrez Id: 3480
Gene Symbol: IGF1R
IGF1R 		0.300 Biomarker disease CTD_human Brain insulin-like growth factor and neurotrophin resistance in Parkinson's disease and dementia with Lewy bodies: potential role of manganese neurotoxicity. 19276553 2009
Entrez Id: 4914
Gene Symbol: NTRK1
NTRK1 		0.300 Biomarker disease CTD_human Brain insulin-like growth factor and neurotrophin resistance in Parkinson's disease and dementia with Lewy bodies: potential role of manganese neurotoxicity. 19276553 2009
Entrez Id: 177
Gene Symbol: AGER
AGER 		0.300 Biomarker disease CTD_human Evidence of oxidative stress in the neocortex in incidental Lewy body disease. 16141792 2005
Entrez Id: 4099
Gene Symbol: MAG
MAG 		0.300 Biomarker disease CTD_human Brain insulin-like growth factor and neurotrophin resistance in Parkinson's disease and dementia with Lewy bodies: potential role of manganese neurotoxicity. 19276553 2009
Entrez Id: 4915
Gene Symbol: NTRK2
NTRK2 		0.300 Biomarker disease CTD_human Brain insulin-like growth factor and neurotrophin resistance in Parkinson's disease and dementia with Lewy bodies: potential role of manganese neurotoxicity. 19276553 2009